64 Amongst these cytokines, IL-6, IL-21 and IL-23 all signal through STAT3, and not surprisingly, STAT3 is essential for Th17 development. Indeed, disrupted STAT3 expression in T cells blocks Th17 differentiation,65 and confers resistance to experimental autoimmune Dinaciclib encephalomyelitis (EAE) and colitis.66,67 STAT3 controls the expression
of several key Th17 genes such as il17a, il17f, rora, il6r and il2167–69 but also promotes RORγt while repressing Foxp3 expression,65 so STAT3 is key at all stages of Th17 commitment (Fig. 4). Interestingly, the activation of STAT5 by IL-2 is required for optimal differentiation of Th1, Th2 and Foxp3+ Treg cells, but inhibits the development of Th17 cells.70 Indeed, STAT5 binds several sites on the il17 promoter and directly antagonizes STAT3 transcriptional activity,71 showing that STAT3 and STAT5 exert polar opposite effects on IL-17 expression in the context of Th17 differentiation (Fig. 4). This suggests that STAT5 is an essential regulator of CD4+ T-cell plasticity because IL-2 promotes Th1 and Th2 responses, whereas the absence of IL-2 favours the emergence of Th17 cells, as summarized in Table 1. The SOCS3 protein is a well known inhibitor of STAT3 activation in various cell types, and in particular inhibits IL-6 and IL-23 signalling in CD4+ T cells60–62 (Fig. 4). As might have been expected, SOCS3 deletion in T cells favours IL-17
secretion in vitro62 and in vivo,72 whereas enforced expression of SOCS3 Ferroptosis inhibitor review inhibits polarization towards Th17 and delays the onset
of EAE.61 Moreover, mutation of the SOCS3 binding site on gp130 results in increased IL-17 secretion60 and spontaneous arthritis.73 Finally, it has been proposed that TGF-β inhibits SOCS3 expression, and subsequently prolongs STAT3 activation, which perhaps explains how TGF-β enhances Th17 differentiation.74 Therefore, SOCS3 clearly inhibits the development of Th17 cells, but SOCS1 and SOCS2 appear to have the opposite effect. Indeed, disruption of SOCS1 expression in T cells strongly inhibits Th17 differentiation and diminishes disease in EAE models.61 This is associated with increased IFN-γ-mediated STAT1 activation, enhanced SOCS3 levels, attenuated STAT3 phosphorylation and reduced TGF-β transcriptional activity. These observations indicate that SOCS1 Endonuclease promotes Th17 differentiation possibly by modulating TGF-β signalling, but also indirectly by preventing Th1 lineage polarization and by regulating SOCS3 levels. Interestingly, SOCS2-deficient CD4+ T cells also have impaired IL-17 secretion, consistent with reduced STAT3 activation and elevated SOCS3 levels.59 Therefore the positive effect of SOCS1 and SOCS2 on Th17 differentiation might well be simply the consequence of increased SOCS3 levels, which confirms that the regulation of STAT3 activation by SOCS3 is an essential mechanism to limit Th17 development.
No related posts.